Form of] WARRANT To Purchase _______ Thousand (__,000) Shares of Common Stock of PETVIVO HOLDINGS, INC.PetVivo Holdings, Inc. • July 17th, 2024 • Surgical & medical instruments & apparatus
Company FiledJuly 17th, 2024 IndustryTHIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES OF THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT PURSUANT TO REGISTRATION UNDER THE ACT OR PURSUANT TO AN EXEMPTION THEREFROM, AND EXCEPT AS PERMITTED UNDER APPLICABLE STATE SECURITIES LAWS. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Preferred Stock and Warrant Offering - $0.40 Per Unit July __, 2024Subscription Agreement and Investment Letter • July 17th, 2024 • PetVivo Holdings, Inc. • Surgical & medical instruments & apparatus
Contract Type FiledJuly 17th, 2024 Company IndustryPetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up units (collectively, the “Units” and individually a “Unit”), each Unit consisting of one (1) share of PetVivo series A convertible preferred stock and one (1) common stock purchase warrant to purchase one (1) share of PetVivo common stock pursuant to this Subscription Agreement (“Agreement”). Furthermore, each Unit shall be made available for purchase at Forty Cents ($0.40) per Unit. This private offering is being made pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (“Securities Act”). Offers and sales of the Units will be made only to “accredited investors” as defined in Rule 501 of the Securities Act. The offering price of the Units has been determined arbitrarily by the management of PetVivo, and bears no particular relationship to our net worth, revenues or any other standard criteria of value.